K.J. Harrison & Partners’s Edwards Lifesciences EW Stock Holding History

K.J. Harrison & Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,300	Closed	-$264K	–	285
2020 Q3	$264K	Hold	3,300	–	–	0.05%	193
2020 Q2	$228K	Hold	3,300	–	–	0.06%	173
2020 Q1	$207K	Hold	3,300	–	–	0.12%	115
2019 Q4	$257K	Hold	3,300	–	–	0.06%	170
2019 Q3	$242K	Hold	3,300	–	–	0.07%	150
2019 Q2	$203K	Buy	+3,300	New	+$200K	0.06%	137

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

K.J. Harrison & Partners's EW Position: Q4 2020 in Review

K.J. Harrison & Partners sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 3,300 shares — an estimated $264K sold.

K.J. Harrison & Partners first reported a position in EW in Q2 2019 and held it in 6 quarters. The position peaked at $264K in Q3 2020. 1,158 funds tracked by Wall St. Rank hold EW as of Q4 2020.

K.J. Harrison & Partners reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
K.J. Harrison & Partners sold 3,300 Edwards Lifesciences shares in Q4 2020, an estimated $264K.
K.J. Harrison & Partners first reported a position in Edwards Lifesciences in Q2 2019 and held it in 6 quarters.
K.J. Harrison & Partners's Edwards Lifesciences position peaked at $264K in Q3 2020.
1,158 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on K.J. Harrison & Partners's 13F filing for Q4 2020, filed 8 Feb 2021.